The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Venofer
iron sucrose · IRON SUCROSE 20 mg/mL · Injection, Solution · Intravenous · Fresenius Medical Care Holdings, Inc.
NDC 49230-0530-10 · 10 VIAL, SINGLE-DOSE in 1 BOX / 2.5 mL in 1 VIAL, SINGLE-DOSE · NDA · View full market →
One drug, every price
The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.
ⓘ How this was built
Data sources
- CMS NADAC (pharmacy acquisition, weekly)
- CMS Part B ASP quarterly payment limits
- CMS Maximum Fair Prices (IRA negotiated, NDC-level)
- Medicare Part D Spending by Drug (data.cms.gov, name-matched)
- VA FSS / Big4 federal contract prices (va.gov, twice monthly)
- ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
- California SB-17 WAC filings (list price, per package)
Method
Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
- Medicare Part B pays (ASP+6%)$0.2270per billing unit (1 MG)HCPCS J1756 · Jul 1, 2026
- Part D plans paid (avg)$11.88per dosage unitgross, before rebates — matched by drug name · 2024
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$180.00
Reported to Texas DSHS · 2025 annual filing · Fresenius Kabi Usa
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicare Part B (ASP)
Payment limit per 1 MG
$0.227
HCPCS J1756 · Jul 1, 2026 quarter · typically ASP + 6%
Medicaid spend (2025)
$2.8M
346,148 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- American Regent, Inc.United Statesanalysis · manufacture
- American Regent, Inc.United Statesanalysis
- American Regent, Inc.United Statesmanufacture
- Vifor (International) Inc.Switzerlandapi manufacture · manufacture
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $277.34 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA021135
- TE code
- AB
- Approval date
- Nov 6, 2000
- Patents / exclusivity
- None on file
Shortage history
- Planned discontinuation — Iron Sucrose, Injection, 50 mg/2.5 mL (NDC 67457-957-99)May 21, 2026
Recalls (this NDC)
- Class II · OngoingNov 11, 2024American Regent, Inc. — Presence of Particulate Matter: Potential for glass delamination from the vials.
- Class II · OngoingNov 11, 2024American Regent, Inc. — Presence of Particulate Matter: Potential for glass delamination from the vials.
Manufacturers of iron sucrose (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Fresenius Medical Care Holdings, Inc. | IRON SUCROSE 20 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Mylan Institutional LLC | IRON SUCROSE 100 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional LLC | IRON SUCROSE 200 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| Mylan Institutional LLC | IRON SUCROSE 50 mg/2.5mL | Jul 15, 2026 | Sep 2, 2026 |
| American Regent, Inc. | IRON SUCROSE 20 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Venofer — NDC 49230-0530-10," retrieved September 3, 2026, https://drugdashboards.com/drug/49230053010.
Free to cite with attribution — see how the data is put together.